Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02878330” into the search
box and click “Search”.
• www.clinicaltrialsregister.eu Once you are on the website, click “Home and Search”, then
type “2016-001677-33” in the search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5290C00003” into the search box, and click “Find a Study”.
Full study title: A Phase 2b Randomized, Double-blind, Placebo-controlled Study to
Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended
Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
National Clinical Trials number: NCT02878330
AstraZeneca Protocol Number: D5290C00003
MedImmune, a subsidiary of AstraZeneca, sponsored this study and has its
headquarters in Gaithersburg, United States.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version 1.0 2019_10_04